---

Intraoperative Hypothermia: All Anesthetic Implications

---

Definition and Classification

---

Why Hypothermia Occurs Intraoperatively: The 3-Phase Pattern

1. Redistribution Phase (First Hour) - Most Important

• Anesthetic agents cause peripheral vasodilation, redistributing warm blood from the core to cooler peripheral compartments
• Core temperature drops sharply by 1-1.5°C within the first 30-60 minutes - this is the dominant mechanism
• All volatile agents and propofol reduce the vasoconstriction threshold by 2-4°C
• Spinal and epidural anesthesia similarly abolish normal vasoconstrictive thermoregulatory responses below the block level

2. Linear Cooling Phase (1-3 hours)

• Heat loss to the environment exceeds metabolic heat production
• Four mechanisms of heat loss:
  • Radiation (60%): the dominant route; infrared energy emitted from exposed body surface
  • Convection (15-25%): air currents in cool operating rooms
  • Conduction: direct contact with cold surfaces (table, irrigating fluids, prep solutions)
  • Evaporation: from open body cavities, respiratory tract, skin prep solutions

3. Plateau Phase (After 3-4 hours)

• Thermoregulatory vasoconstriction (even partially preserved under anesthesia) insulates the core
• Core temperature stabilizes, though it remains below normal

---

Risk Factors for Intraoperative Hypothermia

• Age extremes (neonates, elderly) - reduced thermoregulatory capacity and surface area-to-body mass ratio
• Prolonged surgery (> 2-4 hours)
• Large body cavity exposure (open abdominal, thoracic, burn surgery)
• High-flow unhumidified inhalation agents
• Large volumes of room-temperature IV fluids or cold blood products
• Low ambient operating room temperature (typical OR is 18-20°C)
• Regional anesthesia below the block level
• Low preoperative temperature
• Burns, spinal cord injury, malnutrition

---

Anesthetic Implications (System-by-System)

1. Pharmacokinetic and Pharmacodynamic Effects

• MAC decreases ~5-7% per 1°C decrease in core temperature
• At profound hypothermia (~20°C), anesthesia may no longer be needed to prevent movement - EEG silence is achieved at roughly this temperature
• Therefore, the same delivered concentration produces deeper anesthesia than expected - risk of anesthetic overdose

• CYP450-mediated drug clearance (propofol, ketamine, midazolam) decreases proportionally with body temperature
• Plasma concentrations of IV anesthetics rise because of reduced compartmental clearance
• Propofol and ketamine infusion rates must be reduced to achieve the same sedation level
• Hepatic blood flow reduction further impairs drug metabolism

• Hypothermia (~34°C) significantly prolongs recovery from NMBs
• Mechanism: impaired neuromuscular junction function + pharmacokinetic changes (increased plasma concentration due to reduced clearance of steroidal NMBDs like rocuronium and vecuronium)
• Residual neuromuscular blockade at extubation is a major risk - TOF monitoring may be unreliable in hypothermic periphery
• Pulse oximetry on digits is also unreliable in even mild hypothermia due to peripheral vasoconstriction; ear sensors perform better

• Clearance reduced - prolonged respiratory depression risk
• Morphine-6-glucuronide (active metabolite) accumulates

---

2. Cardiovascular Effects

• Arrhythmias: Mild hypothermia causes sinus bradycardia, increased PR and QT intervals. Below 30°C, atrial fibrillation is common; below 28°C, ventricular fibrillation risk rises dramatically
• Myocardial ischemia: Postoperative shivering drives sympathetic discharge → tachycardia, hypertension, increased myocardial O2 demand. Studies show increased incidence of myocardial ischemia and MI in hypothermic patients
• Cardiac output: Initially maintained or increased (catecholamine surge), then decreases with deeper hypothermia
• Systemic vascular resistance: Increased due to thermoregulatory vasoconstriction - raises BP
• "Afterdrop" in cardiac surgery: even after CPB rewarming to 37°C, core temperature drops again in the post-bypass period due to equilibration with still-cool peripheral compartments - can cause myocardial dysfunction and coagulopathy
• At < 28°C: cardiac standstill can occur - the basis for deliberate hypothermia during CPB

---

3. Coagulation and Hematological Effects

• Platelet dysfunction: Hypothermia impairs platelet aggregation and thromboxane A2 production - this occurs at the local wound temperature, not just core temperature
• Coagulation factor activity (enzymatic): All clotting factor enzyme activity decreases with temperature; laboratory PT/aPTT tested at 37°C will appear falsely normal even when the patient has significant coagulopathy at 33-34°C
• Massive transfusion scenario: hypothermia + acidosis + dilutional coagulopathy = lethal triad of trauma
• A 1°C drop in temperature causes approximately a 10% decrease in coagulation factor activity
• Blood transfusion requirements increased with hypothermia
• Clotting factor supplementation does not reverse hypothermia-induced coagulopathy - rewarming is the treatment

---

4. Respiratory Effects

• Shift of the oxygen-hemoglobin dissociation curve to the left (increased Hb affinity for O2) - reduced tissue oxygen delivery
• Decreased respiratory rate and tidal volume with progressive hypothermia
• Bronchospasm possible from cold airway gases (use humidified, warmed circuits)
• Carbon dioxide production decreases (lower metabolic rate) - but CO2 dissolved in blood increases (solubility increases with cooling) - alpha-stat vs pH-stat blood gas management debate during CPB
• Decreased hypoxic pulmonary vasoconstriction

---

5. Neurological Effects

• Reduced cerebral metabolic rate (CMRO2): ~7% reduction per 1°C drop - basis of neuroprotection
• Unlike anesthetic agents which reduce only the electrophysiological component of CMRO2, hypothermia reduces both the basal metabolic and electrophysiological components
• EEG: progressive slowing → burst suppression → isoelectric silence at ~15-18°C (complete EEG suppression)
• Deliberate hypothermia: Used during cardiac surgery with CPB for cerebral and spinal cord protection. However, the IHAST trial (1001 patients) showed no benefit of mild hypothermia (33°C) in aneurysm surgery for neurologic outcome - routine use has declined
• TBI: Clinical trials of hypothermia failed to show outcome benefit in humans despite laboratory promise

---

6. Metabolic and Endocrine Effects

• Hyperglycemia: Insulin secretion suppressed, insulin resistance increased
• Decreased oxygen consumption (useful in deliberate hypothermia, problematic when shivering)
• Shivering on emergence/in PACU: can increase O2 consumption by 200-600% and CO2 production and cardiac output - very poorly tolerated in patients with cardiac or pulmonary disease
• Hypokalemia initially (K+ shifts intracellularly), then hyperkalemia on rewarming
• Metabolic acidosis from poor peripheral perfusion

---

7. Immune and Wound Healing Effects

• Hypothermia reduces cutaneous blood flow via thermoregulatory vasoconstriction, causing tissue hypoxia and failure of humoral immune defense
• Surgical site infection risk increases 3-fold with even mild perioperative hypothermia (core temp drop of 1.9°C triples SSI incidence)
• Impaired neutrophil oxidative killing of bacteria
• Prolonged wound healing, potential anastomotic integrity issues
• CMS (Centers for Medicare and Medicaid Services) has designated perioperative normothermia as a Pay for Performance quality indicator

---

Monitoring Considerations

---

Treatment and Prevention

Active Warming Techniques (most to least effective)

1. Forced-air warming blanket - most effective for active warming; upper and lower body blankets
2. Circulating water warming mattress/blanket - effective; especially for lower body
3. Warmed IV fluids - fluid warmers (mandatory for rapid transfusion); prevent heat loss but do not provide active warming
4. Humidification of breathing circuit - minimizes respiratory heat loss (~10% of total)
5. Increased ambient room temperature - especially important for neonates/infants
6. Reflective (space) blankets - passive insulation only, not active warming

Preoperative Warming

• 30-minute preoperative forced-air warming significantly reduces intraoperative hypothermia by filling the peripheral "heat reservoir" before redistribution can occur

Treatment of Shivering

• Meperidine 10-25 mg IV - most commonly used; acts on kappa-opioid and alpha-2 receptors; most effective anti-shivering drug
• Ondansetron, clonidine, ketamine also effective
• Dexmedetomidine infusion: effective prophylactically
• Intubated patients: small dose of NMB until normothermia achieved (with full monitoring and sedation)
• Forced-air warming device is the definitive treatment

---

Key Anesthetic Decision Points

---

• Miller's Anesthesia, 10e (Chapters 29, 71, 76) - Miller's Anesthesia: drug metabolism/NMB effects, clinical effects section, CPB hypothermia
• Morgan & Mikhail's Clinical Anesthesiology, 7e - maintenance of normothermia, shivering/hypothermia management
• Barash, Cullen & Stoelting's Clinical Anesthesia, 9e - metabolic derangements, massive transfusion
• Sabiston Textbook of Surgery - perioperative hypothermia complications and prevention